Navigation Links
AAHC Examines Nation's Clinical Trials Infrastructure

Report Highlights Improvements, Blueprint for Future

WASHINGTON, Oct. 23 /PRNewswire-USNewswire/ -- The Clinical Trials Landscape: Limitations, Strengths, and Promise, the latest report from the Association of Academic Health Centers (AAHC), provides an overview of the infrastructure for clinical trials in the U.S. and a blueprint for action to improve and enhance clinical trials administration in academic health centers nationwide. The infrastructure for clinical trials in the U.S. -- a rarely studied, yet vital, aspect of the U.S. research enterprise -- is examined in new and different ways in this ground-breaking report. Clinical trials are a critical aspect of America's preeminence in science worldwide as they facilitate discoveries to treat and cure illness and disease and improve the quality of life for countless people.

Based on the observations of organization and governance structures at academic health centers, the report assesses the stresses and challenges, delineates impediments to progress, and suggests agents of change that are the strategic imperatives for leaders to improve and enhance research, clinical trials, and compliance operations.

Key to improvement and change is an innovative "functional process map," which describes and organizes the myriad of activities that span clinical trials administration. "This is a powerful tool for academic health centers to assess and evaluate institutional priorities as they analyze the strength of institutional resources along with personnel capabilities and needs. Academic health center leaders will find it useful to consider this roadmap as they move forward with their clinical trials program," says AAHC president and CEO Dr. Steven Wartman. The map is also critical for ultimately developing IT solutions, where they currently do not exist.

"Clinical trials administration and oversight requires the fullest attention of academic health center leaders and this report focuses on how they can help ensure an enhanced clinical research infrastructure for the nation," added Dr. Wartman.

The Association of Academic Health Centers (AAHC) is a national, non-profit organization that seeks to improve health and well-being through vigorous leadership of the nation's academic health centers. Academic health centers are accredited, degree-granting institutions of higher education that include medical and other health professions schools or programs and hospitals, health systems, or organized health services.

SOURCE Association of Academic Health Centers
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
(Date:12/1/2015)... BOSTON , December 1, 2015 Russia ... phase III clinical trials. 70% of new drugs registered in ... trials in Russia . --> Russia has ... trials. 70% of new drugs registered in Europe ... . --> Russia has always been ...
(Date:12/1/2015)... , Dec. 1, 2015 Relmada Therapeutics, Inc. ... treatment of chronic pain, announced today that the company will ... be held December 1-3 at the Luxe Sunset Boulevard Hotel ... Traversa , CEO of Relmada Therapeutics, will present on Thursday, ... Time). . Please register at least 10 ...
(Date:12/1/2015)...   MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), ... filed an Investigational New Drug Application (IND) with the ... lead fully human antibody product HuMab 5B1 as a ... initiate the Phase I clinical trial early in 2016. ... The planned Phase I trial will evaluate the safety, ...
Breaking Medicine Technology:
(Date:12/1/2015)... NY (PRWEB) , ... December 01, 2015 , ... ... non-traumatic limb amputations in the United States. Podiatrists are well aware that psychology-based ... adopt therapeutic behaviors) are often catastrophic contributors to diseases of the diabetic foot. ...
(Date:12/1/2015)... ... December 01, 2015 , ... For the ... is why Hollister Incorporated has launched the VaPro Plus Pocket™ touch free hydrophilic ... the VaPro touch free catheter portfolio,” said Michael Gresavage, Vice President North America. ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next IT Healthcare, the leader ... in this year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the ... finalist in the category of Digital Solutions for its innovative, industry-leading product, Alme ...
(Date:12/1/2015)... ... 2015 , ... TCS Healthcare Technologies (TCS), a leading provider ... is pleased to announce that VIP Care Services, a Caprock Health Group affiliate ... Complete Care™ Management to back their collaborative catastrophic case management initiatives. ACUITY Complete ...
(Date:12/1/2015)... GA (PRWEB) , ... December 01, 2015 , ... ... supports SACC-GA and SACC-USA through membership and leadership since 2008. Gary ... Chair for SACC-USA . Gary has spent a significant amount of time ...
Breaking Medicine News(10 mins):